Výsledky vyhľadávania - "Antitubercular Agents - therapeutic use"

Submentale zwelling bij man uit Ethiopië

Autori: Klunder, L S Louwe, M S Vissink, A a ďalší

Zdroj: Nederlands Tijdschrift Voor Tandheelkunde. 132:390-394

Predmety: Male, Adult, Tooth Extraction/adverse effects, Lymph Node/diagnosis, Antitubercular Agents/therapeutic use, Mycobacterium tuberculosis/isolation & purification, Humans, Tuberculosis, Ethiopia

Characteristics of children and adolescents with multidrug-resistant and rifampicin-resistant tuberculosis and their association with treatment outcomes: a systematic review and individual participant data meta-analysis: a systematic review and individual participant data meta-analysis

Autori: Garcia-Prats, Anthony J Garcia-Cremades, Maria Cox, Vivian a ďalší

Prispievatelia: Garcia-Prats, Anthony J Garcia-Cremades, Maria Cox, Vivian a ďalší

Zdroj: The Lancet Child & Adolescent Health, 9, 2, pp. 100-111

Predmety: Male, Adolescent, Antitubercular Agents/therapeutic use, Antitubercular Agents, Infant, Multidrug-Resistant/drug therapy, Treatment Outcome, Child, Preschool, Tuberculosis, Multidrug-Resistant, Tuberculosis, Humans, Rifampin/therapeutic use, Female, Rifampin, Pulmonary Diseases - Radboud University Medical Center, Preschool, Child, Antibiotics, Antitubercular

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39855750
https://hdl.handle.net/2066/315855
https://repository.ubn.ru.nl//bitstream/handle/2066/315855/315855.pdf
https://rivm.openrepository.com/handle/10029/628233

Long-Term Self-Administered Outpatient Parenteral Antimicrobial Therapy in the Treatment of Tuberculosis

Autori: A. Rauch N. Köhler T. T. Brehm a ďalší

Zdroj: Drugs

Predmety: Male, Adult, Antitubercular Agents, Self Administration, Female [MeSH], Adult [MeSH], Humans [MeSH], Infusions, Parenteral [MeSH], Treatment Outcome [MeSH], Retrospective Studies [MeSH], Antitubercular Agents/therapeutic use [MeSH], Tuberculosis/drug therapy [MeSH], Antitubercular Agents/adverse effects [MeSH], Outpatients [MeSH], Male [MeSH], Tuberculosis, Multidrug-Resistant/drug therapy [MeSH], Antitubercular Agents/administration, Germany [MeSH], Original Research Article, Self Administration [MeSH], Treatment Outcome, Germany, Outpatients, Tuberculosis, Multidrug-Resistant, Humans, Tuberculosis, Female, Infusions, Parenteral, Retrospective Studies

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39733377
https://repository.publisso.de/resource/frl:6517897

Tuberculosis impacts multiple aspects in quality of life in a Romanian cohort of drug‐susceptible and drug resistant patients: A patient‐reported outcome measures study: A patient-reported outcome measures study

Autori: Ioana Margineanu Teodora Butnaru Marjolein Lam a ďalší

Zdroj: Tropical Medicine & International Health. 29:584-593

Predmety: Tuberculosis/drug therapy, Male, Adult, Romania, Antitubercular Agents/therapeutic use, Antitubercular Agents, Multidrug-Resistant/drug therapy, Middle Aged, 3. Good health, Young Adult, Cross-Sectional Studies, Tuberculosis, Multidrug-Resistant, Quality of Life, Humans, Tuberculosis, Female, Patient Reported Outcome Measures, Aged

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38794852
https://research.rug.nl/en/publications/2838553d-2af7-4869-88e8-a7160484588c
https://hdl.handle.net/11370/2838553d-2af7-4869-88e8-a7160484588c
https://doi.org/10.1111/tmi.13996

Genetic polymorphisms and adverse reactions to antituberculosis therapy

Autori: Gunter, Hannah M Choshi, Phuti Chimbetete, Tafadzwa a ďalší

Predmety: Antitubercular Agents - adverse effects, Antitubercular Agents - therapeutic use, Drug-Related Side Effects and Adverse Reactions - genetics, Humans, Pharmacogenetics - methods, Pharmacogenomic Testing - methods, Polymorphism, Genetic - genetics, Tuberculosis - drug therapy, Tuberculosis - genetics, Tuberculosis, Multidrug-Resistant - drug therapy, Multidrug-Resistant - genetics

Popis súboru: pdf

Relation: ispartof: Pharmacogenomics spage 207 epage 221 issue 5-6 vol 26; WOS:001512219200001; 991005791873107891; https://researchportal.murdoch.edu.au/view/delivery/61MUN_INST/12180384160007891/13180384150007891; alma:61MUN_INST/bibs/991005791873107891

Dostupnosť: https://doi.org/10.1080/14622416.2025.2509479
https://researchportal.murdoch.edu.au/esploro/outputs/journalArticle/Genetic-polymorphisms-and-adverse-reactions-to/991005791873107891
https://researchportal.murdoch.edu.au/view/delivery/61MUN_INST/12180384160007891/13180384150007891

Concomitant parasite infections influence tuberculosis immunopathology and favor rapid sputum conversion of pulmonary tuberculosis patients

Autori: Yeboah, Augustine Vivekanandan, Monikamira Adankwah, Ernest a ďalší

Zdroj: Ann Clin Microbiol Antimicrob
Annals of Clinical Microbiology and Antimicrobials, Vol 23, Iss 1, Pp 1-7 (2024)

Predmety: Male, Adult, 0301 basic medicine, Helminthiasis, Antitubercular Agents, RM1-950, Infectious and parasitic diseases, RC109-216, Microbiology, Ghana, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Tuberculosis, Humans, Animals, Tuberculosis, Pulmonary, IL-6, Protozoan Infections, Co-infections, Coinfection, Interleukin-6, Brief Report, Sputum, Mycobacterium tuberculosis, Middle Aged, QR1-502, Treatment efficacy, Cytokines, Female, Therapeutics. Pharmacology, Male [MeSH], Tuberculosis, Pulmonary/immunology [MeSH], Sputum/microbiology [MeSH], Coinfection/microbiology [MeSH], Female [MeSH], Ghana [MeSH], Adult [MeSH], Helminthiasis/complications [MeSH], Humans [MeSH], Tuberculosis, Pulmonary/complications [MeSH], Mycobacterium tuberculosis/immunology [MeSH], Antitubercular Agents/therapeutic use [MeSH], Middle Aged [MeSH], Coinfection/parasitology [MeSH], Protozoan Infections/complications [MeSH], Animals [MeSH], Cytokines/blood [MeSH], Sputum/parasitology [MeSH], Young Adult [MeSH], Interleukin-6/blood [MeSH], Helminthiasis/immunology [MeSH], Coinfection/immunology [MeSH]

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39511560
https://doaj.org/article/7972bf01154b41d2b90195948985b492
https://repository.publisso.de/resource/frl:6517554

Global treatment outcomes of extensively drug-resistant tuberculosis in adults: A systematic review and meta-analysis

Autori: Ole Skouvig Pedersen Freja Breth Holmgaard Mads Kristian Duborg Mikkelsen a ďalší

Zdroj: Skouvig Pedersen, O, Holmgaard, F B, Mikkelsen, M K D, Lange, C, Sotgiu, G, Lillebaek, T, Andersen, A B, Wejse, C M & Dahl, V N 2023, 'Global treatment outcomes of extensively drug-resistant tuberculosis in adults: A systematic review and meta-analysis', The Journal of infection, vol. 87, no. 3, pp. 177-189. https://doi.org/10.1016/j.jinf.2023.06.014
Pedersen, O S, Holmgaard, F B, Mikkelsen, M K D, Lange, C, Sotgiu, G, Lillebaek, T, Andersen, A B, Wejse, C M & Dahl, V N 2023, ' Global treatment outcomes of extensively drug-resistant tuberculosis in adults : A systematic review and meta-analysis ', Journal of Infection, vol. 87, no. 3, pp. 177-189 . https://doi.org/10.1016/j.jinf.2023.06.014

Predmety: Extensively Drug-Resistant Tuberculosis/drug therapy, Adult, Drug-resistant tuberculosis, Pre-extensively drug-resistant tuberculosis, Antitubercular Agents/therapeutic use, Extensively Drug-Resistant Tuberculosis, Antitubercular Agents, Treatment outcomes, 3. Good health, Tuberculosis, Pulmonary/drug therapy, Treatment Outcome, Pregnancy, Tuberculosis, Multidrug-Resistant, Tuberculosis, Humans, Female, Extensively drug-resistant tuberculosis, Tuberculosis, Multidrug-Resistant/drug therapy, Tuberculosis, Pulmonary

Popis súboru: application/pdf

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/37356629
https://pure.au.dk/portal/en/publications/c37fe070-89e9-4a38-9a1c-28f2e379e384
https://curis.ku.dk/ws/files/366986695/1_s2.0_S0163445323003377_main.pdf
https://pure.au.dk/portal/en/publications/c37fe070-89e9-4a38-9a1c-28f2e379e384
https://doi.org/10.1016/j.jinf.2023.06.014
https://pure.au.dk/ws/files/384334091/1-s2.0-S0163445323003377-main.pdf
http://www.scopus.com/inward/record.url?scp=85164367441&partnerID=8YFLogxK

Pretomanid-resistant tuberculosis

Autori: Niklas Koehler Sönke Andres Matthias Merker a ďalší

Zdroj: Journal of Infection, 86, 5, pp. 520-524
The Journal of infection, vol. 86, no. 5, pp. 520-524

Predmety: 0301 basic medicine, 0303 health sciences, 03 medical and health sciences, Nitroimidazoles, Tuberculosis, Multidrug-Resistant, Antitubercular Agents, Humans, Tuberculosis/drug therapy, Antitubercular Agents/pharmacology, Antitubercular Agents/therapeutic use, Tuberculosis, Multidrug-Resistant/drug therapy, Radboud University Medical Center, Tuberculosis, Radboudumc 4: lnfectious Diseases and Global Health Clinical Pharmacy

Popis súboru: application/pdf

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/36738862
https://hdl.handle.net/2066/292381
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_07AF0EE6CA119
https://serval.unil.ch/resource/serval:BIB_07AF0EE6CA11.P001/REF.pdf
https://serval.unil.ch/notice/serval:BIB_07AF0EE6CA11

Pancreatitis delays the absorption of first-line anti-TB drugs

Autori: Lever, S Akkerman, O W Dekkers, B G J

Zdroj: The International Journal of Tuberculosis and Lung Disease. 28:163-165

Predmety: Pancreatitis, Antitubercular Agents/therapeutic use, Tuberculosis, Multidrug-Resistant, Antitubercular Agents, Tuberculosis, Pancreatitis/drug therapy, Humans, Multidrug-Resistant/drug therapy

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38454182
https://research.rug.nl/en/publications/99982df6-d276-4176-ae5f-6c20fb422fe3
https://doi.org/10.5588/ijtld.23.0274
https://hdl.handle.net/11370/99982df6-d276-4176-ae5f-6c20fb422fe3

Drug-induced hepatotoxicity and association with slow acetylation variants NAT2*5 and NAT2*6 in Cameroonian patients with tuberculosis and HIV co-infection

Autori: Cho, Frederick Nchang Achidi, Eric A Enoh, Jude Eteneneng a ďalší

Zdroj: BMC Infect Dis
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-13 (2024)

Predmety: Male, Adult, 0301 basic medicine, Pharmacogenomic Variants, Arylamine N-Acetyltransferase, Antitubercular Agents, HIV Infections, Drug-induced hepatotoxicity, Infectious and parasitic diseases, RC109-216, Polymorphism, Single Nucleotide, Young Adult, 03 medical and health sciences, Humans, Tuberculosis, Cameroon, HIV Infections/complications [MeSH], Polymorphism, Single Nucleotide [MeSH], Acetylation [MeSH], Pharmacogenomic Variants [MeSH], Tuberculosis/drug therapy [MeSH], Antitubercular Agents/adverse effects [MeSH], Male [MeSH], Pharmacogenetics, Tuberculosis/genetics [MeSH], Female [MeSH], Coinfection [MeSH], Adult [MeSH], Tuberculosis/complications [MeSH], Humans [MeSH], Co-infection, HIV, Antitubercular Agents/therapeutic use [MeSH], Middle Aged [MeSH], Chemical and Drug Induced Liver Injury/genetics [MeSH], Arylamine N-Acetyltransferase/genetics [MeSH], HIV Infections/drug therapy [MeSH], Research, Cameroon/epidemiology [MeSH], Young Adult [MeSH], 0303 health sciences, Coinfection, Acetylation, Middle Aged, 3. Good health, Female, Chemical and Drug Induced Liver Injury

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39085767
https://doaj.org/article/45dbcd854c574d1a83341fa60c612ae4
https://pure.amsterdamumc.nl/en/publications/627e1e9d-f97c-4563-b045-ddcbdbe975e5
https://doi.org/10.1186/s12879-024-09638-w
https://repository.publisso.de/resource/frl:6519375
https://discovery-pp.ucl.ac.uk/id/eprint/10195425/

9 months of delamanid, linezolid, levofloxacin, and pyrazinamide versus conventional therapy for treatment of fluoroquinolone-sensitive multidrug-resistant tuberculosis (MDR-END): a multicentre, randomised, open-label phase 2/3 non-inferiority trial in South Korea

Autori: Jeongha, Mok Myungsun, Lee Deog Kyeom, Kim a ďalší

Prispievatelia: Jeongha, Mok Myungsun, Lee Deog Kyeom, Kim a ďalší

Zdroj: The Lancet. 400:1522-1530

Predmety: Male, 0301 basic medicine, Antitubercular Agents, Pyrazinamide* / therapeutic use, Levofloxacin, 03 medical and health sciences, 0302 clinical medicine, Drug Therapy, Tuberculosis, Multidrug-Resistant, Tuberculosis, Humans, Levofloxacin / therapeutic use, Antitubercular Agents / therapeutic use, Linezolid / therapeutic use, Linezolid, 16. Peace & justice, Pyrazinamide, 3. Good health, Multidrug-Resistant* / drug therapy, Treatment Outcome, Combination, Fluoroquinolones / therapeutic use, Female, Drug Therapy, Combination, Fluoroquinolones

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/36522208

Trends in the availability and prices of quality-assured tuberculosis drugs: a systematic analysis of Global Drug Facility Product Catalogs from 2001 to 2024

Autori: Stefan Kohler Jay Achar Christiaan Mulder a ďalší

Zdroj: Global Health
Globalization and Health, Vol 20, Iss 1, Pp 1-16 (2024)

Predmety: 0301 basic medicine, 0303 health sciences, Humans [MeSH], Antitubercular Agents/therapeutic use [MeSH], Tuberculosis drugs, Tuberculosis/drug therapy [MeSH], Drug Costs [MeSH], Drug costs, Research, Antitubercular Agents/economics [MeSH], Drug supply, Cost analysis, Global Drug Facility, Global Health [MeSH], Tuberculosis, Price trends, Antitubercular Agents, Global Health, Drug Costs, 3. Good health, 03 medical and health sciences, Humans, Public aspects of medicine, RA1-1270

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38918859
https://doaj.org/article/ce1b657b1c804923a2395652b1d75e15
https://repository.publisso.de/resource/frl:6504779

Is it time for new fixed-dose combinations and revised weight bands for children with drug-susceptible TB?

Autori: Gafar, F Alffenaar, J-W C

Zdroj: The International Journal of Tuberculosis and Lung Disease. 27:345-347

Predmety: Drug Combinations, Antitubercular Agents/therapeutic use, Antitubercular Agents, Isoniazid, Humans, Tuberculosis, Child

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/37143226
https://research.rug.nl/en/publications/8287e515-b96d-465b-a5b0-c46f4512553a
https://hdl.handle.net/11370/8287e515-b96d-465b-a5b0-c46f4512553a
https://doi.org/10.5588/ijtld.23.0081

Bedaquiline exposure in people with drug-resistant TB treated for diabetes: analysis of two phase 2 trials: analysis of two phase 2 trials

Autori: Bolhuis, M S Akkerman, O W Sturkenboom, M G G a ďalší

Zdroj: The International Journal of Tuberculosis and Lung Disease. 27:335-337

Predmety: Diabetes Complications, Diarylquinolines/therapeutic use, Antitubercular Agents/therapeutic use, Tuberculosis, Multidrug-Resistant, Antitubercular Agents, Tuberculosis, Humans, Multidrug-Resistant/complications, Diabetes Complications/complications, Diarylquinolines

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/37035978

Is body height a prognostic marker for outcome of tuberculosis treatment?

Autori: Frederikke Bach Christian Wejse Merete Storgaard a ďalší

Zdroj: Bach, F, Wejse, C, Storgaard, M & Patsche, C B 2022, 'Is body height a prognostic marker for outcome of tuberculosis treatment?', Infectious Diseases, vol. 54, no. 7, pp. 538-541. https://doi.org/10.1080/23744235.2022.2047777

Predmety: 0301 basic medicine, 0303 health sciences, 03 medical and health sciences, Treatment Outcome, Antitubercular Agents/therapeutic use, Tuberculosis, Multidrug-Resistant, Antitubercular Agents, Humans, Tuberculosis, Multidrug-Resistant/drug therapy, Prognosis, Body Height

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/35285382
https://pure.au.dk/portal/en/publications/59748ea5-cab6-47ba-a978-98944c622d41
http://www.scopus.com/inward/record.url?scp=85126686297&partnerID=8YFLogxK
https://doi.org/10.1080/23744235.2022.2047777

Endobronchial tuberculosis

Autori: Eskandari, Siawosh K Akkerman, Onno W

Zdroj: Eskandari, S K & Akkerman, O W 2024, 'Endobronchial tuberculosis', Lancet Infectious Diseases, vol. 24, no. 5, e343. https://doi.org/10.1016/S1473-3099(24)00057-4

Predmety: Humans, Mycobacterium tuberculosis/isolation & purification, Male, Antitubercular Agents/therapeutic use, Tuberculosis, Pulmonary/diagnosis, Bronchial Diseases/microbiology, Bronchoscopy, Female, Tuberculosis/diagnosis

Popis súboru: application/pdf

Relation: info:eu-repo/semantics/altIdentifier/pmid/38670683; info:eu-repo/semantics/altIdentifier/hdl/https://hdl.handle.net/11370/24814786-3760-401d-933d-17bc287368f2; info:eu-repo/semantics/altIdentifier/pissn/1473-3099; info:eu-repo/semantics/altIdentifier/eissn/1474-4457

Dostupnosť: https://hdl.handle.net/11370/24814786-3760-401d-933d-17bc287368f2
https://research.rug.nl/en/publications/24814786-3760-401d-933d-17bc287368f2
https://doi.org/10.1016/S1473-3099(24)00057-4
https://pure.rug.nl/ws/files/1049120679/1-s2.0-S1473309924000574-main.pdf
https://www.scopus.com/pages/publications/85190889905

Triage test for all-oral drug-resistant tuberculosis (DR-TB) regimen : a phase IV study to assess effectiveness, feasibility, acceptability and cost-effectiveness of the Xpert MTB/XDR assay for rapid triage and treatment of DR-TB

Autori: Naidoo, Kogieleum Naidoo, Anushka Abimiku, Alash'le G a ďalší

Prispievatelia: Naidoo, Kogieleum Naidoo, Anushka Abimiku, Alash'le G a ďalší

Predmety: Humans, Triage/methods, Mycobacterium tuberculosis/drug effects, Cost-benefit analysis, Antitubercular agents/therapeutic use, Tuberculosis, multidrug-resistant/drug therapy, Sputum/microbiology, Rifampin/therapeutic use, Feasibility studies, South Africa, Extensively drug-resistant tuberculosis/drug therapy, Ethiopia, Nigeria, Adult, Administration, oral, NDAS, SDG 3 - Good Health and Well-being, MCC

Popis súboru: application/pdf

Relation: BMJ Open; 308292163; 85211208351; https://hdl.handle.net/10023/30999

Dostupnosť: https://hdl.handle.net/10023/30999
https://doi.org/10.1136/bmjopen-2024-084722

Clinical features and long-term treatment outcomes in choroidal tuberculoma

Autori: Dong Hyun Lee Hyuna Cho Junwon Lee a ďalší

Prispievatelia: Dong Hyun Lee Hyuna Cho Junwon Lee a ďalší

Zdroj: Graefe's Archive for Clinical and Experimental Ophthalmology. 260:1641-1650

Predmety: Adult, Male, 0301 basic medicine, Antitubercular Agents, Tuberculosis, Ocular, Ocular* / diagnosis, Uveitis, 03 medical and health sciences, 0302 clinical medicine, Choroid Diseases* / diagnosis, Tuberculosis, Humans, Tuberculoma, Choroid Diseases* / drug therapy, Antitubercular Agents / therapeutic use, Retrospective Studies, Tuberculoma* / drug therapy, Choroid Diseases, Middle Aged, Eye neoplasm, Tuberculoma* / diagnosis, 3. Good health, Ocular* / drug therapy, Treatment Outcome, Choroidal tuberculoma, Female

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/34735633
https://europepmc.org/article/MED/34735633
https://www.ncbi.nlm.nih.gov/pubmed/34735633
https://link.springer.com/article/10.1007/s00417-021-05474-9

Clinical spectrum of active tuberculosis in patients with systemic lupus erythematosus

Autori: Amita Aggarwal Able Lawrence Ramnath Misra a ďalší

Zdroj: Muhammed, H, Jain, A, Pattanaik, S S, Chatterjee, R, Naveen, R, Kabeer, H, Gupta, L, Misra, D P, Agarwal, V, Lawrence, A, Misra, R & Aggarwal, A 2021, 'Clinical spectrum of active tuberculosis in patients with systemic lupus erythematosus', Rheumatology International, vol. 41, no. 12, pp. 2185-2193. https://doi.org/10.1007/s00296-021-04933-0

Predmety: Tuberculosis/drug therapy, Adult, Male, Lupus Erythematosus, Lupus Erythematosus, Systemic/epidemiology, Antitubercular Agents/therapeutic use, Mycobacterium tuberculosis/isolation & purification, Antitubercular Agents, India, Mycobacterium tuberculosis, Systemic/epidemiology, 3. Good health, India/epidemiology, 03 medical and health sciences, 0302 clinical medicine, Risk Factors, Prevalence, Humans, Lupus Erythematosus, Systemic, Tuberculosis, Female, Retrospective Studies

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/34191047
https://research.manchester.ac.uk/en/publications/9e511d6b-debc-4d83-9a48-eb06b7c529ab
https://doi.org/10.1007/s00296-021-04933-0
https://link.springer.com/article/10.1007/s00296-021-04933-0

Post-tuberculosis treatment paradoxical reactions

Autori: Hermans, Sabine M. Akkerman, Onno W. Meintjes, Graeme a ďalší

Zdroj: Infection

Predmety: Male, 0301 basic medicine, 0303 health sciences, Incidence, Paradoxical response, Antitubercular Agents, Review, Tuberculosis, Lymph Node, Female [MeSH], Tuberculosis/epidemiology [MeSH], Recurrence, Tuberculosis/diagnosis [MeSH], Humans [MeSH], Paradoxical reaction, Incidence [MeSH], Antitubercular Agents/therapeutic use [MeSH], Tuberculosis, Lymph Node/diagnosis [MeSH], Recurrence [MeSH], Paradoxical upgrading, Tuberculosis/drug therapy [MeSH], Male [MeSH], Tuberculosis, Tuberculosis, Lymph Node/drug therapy [MeSH], Lymph node, 03 medical and health sciences, Humans, Female

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/38955990
https://research.rug.nl/en/publications/b3f831d6-6da9-4c1f-aa66-e5f8e4e7c891
https://hdl.handle.net/11370/b3f831d6-6da9-4c1f-aa66-e5f8e4e7c891
https://doi.org/10.1007/s15010-024-02310-0
https://repository.publisso.de/resource/frl:6508140